PROCEPT BioRobotics Corporation
NASDAQ:PRCT
Overview | Financials
Company Name | PROCEPT BioRobotics Corporation |
Symbol | PRCT |
Currency | USD |
Price | 96.23 |
Market Cap | 5,234,404,002 |
Dividend Yield | 0% |
52-week-range | 29.71 - 99.34 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Reza Zadno Ph.D. |
Website | https://www.procept-biorobotics.com |
An error occurred while fetching data.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD